Search hospitals > Pennsylvania > York
WellSpan Health-York Cancer Center
Claim this profileYork, Pennsylvania 17403
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Breast cancer
Conducts research for Cancer
129 reported clinical trials
9 medical researchers
Summary
WellSpan Health-York Cancer Center is a medical facility located in York, Pennsylvania. This center is recognized for care of Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Breast cancer, Cancer and other specialties. WellSpan Health-York Cancer Center is involved with conducting 129 clinical trials across 167 conditions. There are 9 research doctors associated with this hospital, such as Amit B. Shah, Chanh T. Huynh, Dan Sotirescu, and Joseph Kannarkatt.Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage II
Stage I
2Breast Cancer
Global LeaderER positive
HER2 negative
PR positive
Top PIs
Amit B. ShahWellSpan Health-York Cancer Center4 years of reported clinical research
Studies Prostate Cancer
Studies Breast Cancer
23 reported clinical trials
65 drugs studied
Chanh T. HuynhAdams Cancer Center2 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
21 reported clinical trials
38 drugs studied
Dan SotirescuEphrata Cancer Center6 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
11 reported clinical trials
28 drugs studied
Joseph KannarkattWellSpan Medical Oncology and Hematology4 years of reported clinical research
Studies Lung Cancer
Studies Lung Carcinoma
7 reported clinical trials
31 drugs studied
Clinical Trials running at WellSpan Health-York Cancer Center
Lung Cancer
Breast Cancer
Prostate Cancer
Breast cancer
Cancer
Small Cell Lung Cancer
Non-Small Cell Lung Cancer
Pancreatic Cancer
Prostate Adenocarcinoma
Melanoma
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting2 awards Phase 312 criteria
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting2 awards Phase 314 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at WellSpan Health-York Cancer Center?
WellSpan Health-York Cancer Center is a medical facility located in York, Pennsylvania. This center is recognized for care of Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Breast cancer, Cancer and other specialties. WellSpan Health-York Cancer Center is involved with conducting 129 clinical trials across 167 conditions. There are 9 research doctors associated with this hospital, such as Amit B. Shah, Chanh T. Huynh, Dan Sotirescu, and Joseph Kannarkatt.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.